Skip to main content
. 2022 Jan 13;8:815881. doi: 10.3389/fmed.2021.815881

Table 5.

Adverse events collected.

6 months (n = 115) 1 year (n = 79) 2 years (n = 52) ≥3 years (n = 24) p-value
Adverse events. n (%) 0.013
Infections (upper tract/genito-urinary tract/abdominal/fungal) 8 (7) 16 (20) 10 (19) 3 (12)
Toxicity 0 2 (2) 0 0
Alteration of stool habit 2 (2) 0 0 0
Psychiatric disturbance 1 (1) 0 0 0